As Executive Vice President of Market Access and Customer Solutions at PhyzData, Mike provides business strategies of all portfolio management. Within his roles, he ensures the success of the widest variety of strategic projects across departmental segments, applies strategic business development, contract negotiations, network development, marketing & outreach strategies, and other business development initiatives that cultivate opportunities that affect client segments. Identify pressing market factors and drive strategic business strategy for all facets related to the specialty market.
With more than 19+ years of pharmaceutical and biotech industry experience, including roles in national and regional managed markets, specialty supply channels, sales management and specialty brand management, Mr. Baldzicki offers strategic insight into specialty pharmacy trends, distribution, contracting, reimbursement, and the application of health outcomes and economic evidence to prove value proposition. He is a recognized leader in the specialty pharmaceutical market for developing and implementing key payer and specialty pharmacy agreements that result in documented savings for specialty market segments.
Mr. Baldzicki held roles in senior executive management within the specialty pharmacy supply group, pharmaceutical and biotech industry of managed markets, group purchasing organizations, specialty wholesale, and integrated delivery networks. He assumed roles within the pharmaceutical organization such as Bayer Healthcare, Bristol-Myers Squibb, Enzon BioTech, Baxter BioScience, as well as roles within the distribution channel of AmerisourceBergen specialty groups, Diplomat/BioRx Specialty Pharmacy, Armada Health Care, to other manufacturer & specialty pharmacy home infusion companies. He brings particular expertise in business development, managed markets, specialty pharmacy, hospital systems, reimbursement, and brand management for biologics, including specialty infusion therapies for bloods products, hematology, oncology, and other rare orphan drugs.
Mr. Baldzicki is active in the biotech community and is an Advisor/Faculty member of the Academy of Managed Care Pharmacy (AMCP) for Specialty Pharmacy Advisory Group & Biosimilars Partnership Forum, Faulty Board Member of the American Journal of Managed Care (AJMC) Specialty Pharmacy for ACOs, Guidepoint Global Committee Member for Specialty Pharmacy, and was 2014 Editorial Board Member for Specialty Pharmacy Times.
Mr. Baldzicki has published abstracts and articles surrounding plasma-based infusion therapy, managed markets, and specialty pharmacy. He has spoken at a variety of seminars and WebEx’s within specialty groups and other industry-related settings.
Mr. Baldzicki holds a Bachelor of Arts in Business Management and a Certificate in Clinical Research Compliance and Management (CRCM). He has completed programs in leadership development at Harvard University, Quantum management, Brooks Group, Miller Heiman Account Management, and MD Anderson Center Cancer Courses.
Currently working for Aralez Pharmaceuticals US Inc. as the Executive Director Managed Markets with responsibility in all aspects of Trade and Distribution. Prior to this position, I was Director of Trade, Reimbursement and Access at Vanda Pharmaceuticals Inc. where I was able to build a Specialty Distribution Network and launch the companies first Orphan Medication. Along with these two positions, I have more than 25 years of experience in the Pharmaceutical and Biotech Industry in a number of roles in Managed Markets, Sales and Marketing.
Adam is currently working within the Corporate Market Access, Customer Value Group at Boehringer Ingelheim in Ingelheim, Germany, as a Head of Strategic Market Access Initiatives. In his role, he is responsible for orchestrating and piloting the strategic customer collaboration initiatives and helping to optimise market access excellence standards and processes within the Organisation.
Adam has started his career with Boehringer Ingelheim in 2012 as a Senior Global Payer Strategy Manager working in oncology and HCV in Ingelheim, Germany. He was managing global pricing and market access strategies for the HCV and oncology portfolio and driving the development of innovative market access approaches and payment schemes. He then moved to the UK and Ireland Organisation in 2015 to Head the Pricing and Contracting Team, working across the whole Boehringer Ingelheim prescription medicines portfolio.
Prior to joining Boehringer Ingelheim, Adam worked as a life sciences strategy consultant for IMS Consulting, Truven Analytics and Simon-Kucher & Partners in Belgium, France, Germany, Poland, Romania and The United States. He also worked as a research assistant at Jules Gonin Eye Hospital in Lausanne, Switzerland and as a Junior Project Leader at AnalyCen in Poland and Sweden.
Adam holds an M.Sc. in Molecular Biology and Biotechnology from University of Warsaw, Poland, and a Ph.D. in Neurosciences from University of Geneva, University of Lausanne and EPFL, Switzerland. He has published several articles in international peer-reviewed journals and lectured at international conferences on developmental neuroscience and retinal degeneration.
Susan Malecha has more than 24 years of pharmaceutical/biotechnology industry experience in medical affairs, new product development, managed markets, medical education, medical science liaisons and management. She graduated with a B.S. in pharmacy from Butler University, completed her Doctor of Pharmacy at University of Illinois at Chicago, and earned her Masters of Business Administration from Keller Graduate School of Management. She recently completed the certificate program for Pharmacoeconomics Health and Outcomes Research at University of Washington. She currently is a National Lead, Managed Care Liaison in Medical Affairs at Genentech, supporting Kaiser, Department of Defense, Veterans Administration and other accounts. She was recently the Senior Director, BioOncology Medical Science Liaisons at Genentech. Prior to her biotech positions, Susan was the Senior Director of a clinical field-based team, Director of Managed Care of a field based-medical team and the Director of Medical Education at a large pharmaceutical company.
Susan is an active member of HBA, a former Executive Board Member/Director of Membership for the Southern California Chapter of HBA (2012) HBA Mentoring Program Lead, So. Cal Chapter (2014), and a part of the HBA Field Chapter Advisory Council for Genentech (2014-2015). She is an active presenter/lecturer on medical affairs topics for pharmaceutical industry. She has published papers in Pharmacotherapy, Drug Information Journal, MSL Quarterly, DIA Forum, American Journal of Managed Care Pharmacy and American Journal of Pharmaceutical Education. She published a book, Bridging Scientific Knowledge: The Role of the Medical Science Liaison, in 2009, and she contributed a chapter to Erin Albert’s 2008 book and 2011 e- book, Medical Science Liaisons A to Z.
Scott Sorenson is the currently the Director, Specialty Managed Care at Paragon Healthcare, Inc. whose home office is located in Charlotte, NC.
Scott started his career as a Home Health Administrator, where he oversaw the operations of Medicare and Medicaid home health services (HHA, RN, PT, OT, ST) and learned the importance of the referral, intake and authorization processes under the CMS- II regulations and JCAHO accreditations.
Scott began diversifying his experience when his employer acquired a home infusion service. Post-acquisition Scott worked for Accredo/Medco for 13 years as a hemophilia health account manager and then progressed to a National Account Manager for managed Medicaid payers; where he established his expertise in the growing complexities of onboarding patients. A move to BioRx/Diplomat, for 5 years, as Director, Medicaid and Government Services, where his subject matter expertise continued to develop within the State/Federal Governments’ deployment and implementation of regulatory and legislative actions; thus developing administrative tools that reached CMS, MEDPAC, MACPAC, HCPLAN, Medicare part B/DMEPOS and part D MACs and PDPs.
Scott has been with Paragon Healthcare, Inc. since May 2017 and continues his career with PBM/PSAO credentialing, Government payer applications, contract execution and implementation specific to Paragon Healthcare’s specialty pharmacies.
Pritpal S.Virdee, Senior Vice President and Chief Operating Officer- Senior Health Services leads the operational areas across all product lines, fostering a strong matrix partnership across key operational functions within BCBSM. Pritpal recently came from Anthem, where he held the position of Health Plan President, Medicare – Indiana, Kentucky and Missouri holding profit and loss responsibility for all Medicare products within the regions. He previously served in leadership roles at Walgreens and Express Scripts. Pritpal earned a Bachelor’s degree in Chemical Engineering from Southbank University in London, and a Diploma in Marketing from the Institute of Marketing in the United Kingdom.